Research Letter
104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain
Lido
7655
Vezesque se leu este artigo
2920
Total PDF
4735
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 181 | 78 | 259 |
| 2025 5 | 215 | 76 | 291 |
| 2025 4 | 181 | 55 | 236 |
| 2025 3 | 160 | 57 | 217 |
| 2025 2 | 163 | 86 | 249 |
| 2025 1 | 112 | 56 | 168 |
| 2024 12 | 120 | 62 | 182 |
| 2024 11 | 130 | 67 | 197 |
| 2024 10 | 88 | 72 | 160 |
| 2024 9 | 200 | 93 | 293 |
| 2024 8 | 185 | 115 | 300 |
| 2024 7 | 215 | 130 | 345 |
| 2024 6 | 175 | 82 | 257 |
| 2024 5 | 147 | 72 | 219 |
| 2024 4 | 139 | 94 | 233 |
| 2024 3 | 105 | 72 | 177 |
| 2024 2 | 88 | 79 | 167 |
| 2024 1 | 73 | 47 | 120 |
| 2023 12 | 69 | 55 | 124 |
| 2023 11 | 84 | 85 | 169 |
| 2023 10 | 67 | 90 | 157 |
| 2023 9 | 124 | 73 | 197 |
| 2023 8 | 54 | 33 | 87 |
| 2023 7 | 71 | 45 | 116 |
| 2023 6 | 62 | 50 | 112 |
| 2023 5 | 62 | 33 | 95 |
| 2023 4 | 49 | 16 | 65 |
| 2023 3 | 76 | 49 | 125 |
| 2023 2 | 60 | 33 | 93 |
| 2023 1 | 61 | 32 | 93 |
| 2022 12 | 58 | 31 | 89 |
| 2022 11 | 105 | 57 | 162 |
| 2022 10 | 134 | 51 | 185 |
| 2022 9 | 66 | 66 | 132 |
| 2022 8 | 61 | 52 | 113 |
| 2022 7 | 49 | 62 | 111 |
| 2022 6 | 58 | 60 | 118 |
| 2022 5 | 45 | 35 | 80 |
| 2022 4 | 62 | 52 | 114 |
| 2022 3 | 70 | 83 | 153 |
| 2022 2 | 38 | 41 | 79 |
| 2021 1 | 107 | 97 | 204 |
| 2021 12 | 174 | 98 | 272 |
| 2021 11 | 109 | 72 | 181 |
| 2021 10 | 73 | 73 | 146 |
| 2021 9 | 10 | 3 | 13 |
Mostrar tudo
